Results 21 to 30 of about 1,786 (140)
Clinical Interventions in Aging, 2014 Gregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis, Sacramento, CA, USA Abstract: During the menopausal transition, women experience a number of ...
Wurz GT, Kao CJ, DeGregorio MW
doaj +1 more source
Effect of Ospemifene on Densitometric and Plasma Bone Metabolism Biomarkers in Postmenopausal Women Reporting Vulvar and Vaginal Atrophy (VVA). [PDF]
J Clin Med, 2022 Menopausal hormone deficiency can exert multiple effects on various organs. Vulvovaginal atrophy (VVA) is among the most widespread and disabling post-menopausal disorder.
Maffei S, Guiducci L.
europepmc +2 more sources
International Journal of Women's Health, 2009 SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, S Kellogg, M Krychman
doaj +1 more source
Vulvar Fibroadenoma: A Rare Differential Diagnosis of a Vulvar Mass. [PDF]
Clin Case RepABSTRACT Vulvar fibroadenoma is a rare benign tumor arising from mammary‐type tissue or mammary‐like anogenital glands. A 46‐year‐old Asian woman presented with a slowly enlarging painful labial mass and a history of gynecological disorders. Excision confirmed fibroadenoma, highlighting its inclusion in the differential diagnosis of vulvar masses.
Nili F, Nozheh A, Norouzi M, Gilani A.
europepmc +2 more sources
Sclerosus and atrophic genital Lichen or vulvar craurosis. About a case [PDF]
Medisur, 2016 Sclerosus and atrophic genital Lichen or vulvar craurosis is an affection characterized by a progressive chronic atrophy of the vulvar skin and mucosa, associated to involutive changes in external genitalia. The presentation of this case was motivated by
Graciela Caridad Cabrera Acea +2 more
doaj +3 more sources
The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy [PDF]
Climacteric, 2015 Nick Panay +2 more
exaly +2 more sources
Menopause Review, 2021 During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep.
Wojciech Pięta, Roman Smolarczyk
doaj +1 more source
Using Wood’s Light as a Diagnostic Tool for Vaginal Atrophy [PDF]
Journal of Clinical and Diagnostic Research, 2015 Introduction: Wood’s light lamp is a device that emits ultraviolet (UV) light and is a useful diagnostic tool for dermatologic disorders. The change in the thickness of vaginal mucosa, in vaginal atrophy, causes a change in its colour under Wood’s ...
Mustafa Ulubay +5 more
doaj +1 more source
Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
, 2022 Vaginal laxity (VL) and genitourinary syndrome of menopause (GSM), as well as aesthetic changes in the vulvar skin, often occur together and cause physical, psychological, and functional problems for women and their partners.
Stabile G. +10 more
core +2 more sources
Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study
Drugs in Context, 2020 The changes that occur in sex hormone levels, body composition, and lipid/lipoprotein levels during the menopause transition, together with vascular remodeling, increase the risk of cardiovascular disease (CVD) in postmenopausal women.
Silvia Pilar González Rodríguez
doaj +1 more source